CONSOLIDATED BALANCE SHEETS (UNAUDITED) (EUR €) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
Current Assets
Cash	€ 329	€ 382
Receivable other	37	61
Prepaid expenses	53	54
Total current assets	419	497
Property and equipment, net of accumulated depreciation of E259 at September 30, 2012 and E239 at December 31, 2011	30	49
In-process research and development	2,266	2,266
Goodwill	6,671	6,671
Total assets	9,386	9,483
Current Liabilities
Accounts payable	1,097	1,025
Taxes and social costs payable	4	2
Current portion of notes payable to related Parties	33,637	5,711
Total current liabilities	34,738	6,738
Convertible notes payable to related parties, less current portion	0	25,331
Acquisition-related contingent consideration	6,323	5,753
Total liabilities	41,061	37,822
Shareholders' Equity (Deficit)
Common stock, U.S. $.01 par value; 495,000,000 shares authorized; issued 295,318,813 at September 30, 2012 and 276,017,339 at December 31, 2011	2,468	2,322
Preferred stock, U.S. $.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	33,786	32,732
Deficit accumulated during the development stage	(68,586)	(64,057)
Accumulated other comprehensive income	657	664
Total shareholders' equity (deficit)	(31,675)	(28,339)
Total liabilities and shareholders' equity (deficit)	€ 9,386	€ 9,483